1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Biochips (Microarrays/Lab-on-Chip) Global Market – Forecast To 2021

Biochips (Microarrays/Lab-on-Chip) Global Market – Forecast To 2021

  • May 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 343 pages

Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine.
The global biochips market is broadly classified as micro arrays and lab on chips based on its type. Biochips market is segmented on the basis of application as diagnostic, drug discovery and development, research, forensic and others. Based on the products the biochips market is further segmented into instruments, reagents and consumables, software and services.


The global biochips market is expected to grow at a CAGR of around 17.8% from 2015 to 2021. Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic diseases, approval for personalized medicines and invention of novel technologies in biochips drives the market of biochips. Standardization and quality assurance of biochips, technological ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along with ethical and social issues hinders the market growth.
Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early diagnosis and treatment of diseases, advancement of biochips with its wide application areas shows that biochip market has vast opportunities in the coming years.


North America accounts for the highest market share followed by Europe. Steep rise in genetic diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines and favourable government policies makes U.S. the leader of Biochips market. However, Asian countries especially India and China’s are the fast growing regions with its growing demand for biochips and increasing research investments.


Major players in biochips market include Affymetrix, Inc. (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Cepheid, Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.K.), Hoffman-La-Roche (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).

Table Of Contents

Biochips (Microarrays/Lab-on-Chip) Global Market - Forecast To 2021

1 EXECUTIVE SUMMARY 18
2 INTRODUCTION 26
2.1 KEY TAKE AWAYS 26
2.2 REPORT DESCRIPTION 27
2.3 MARKETS COVERED 28
2.4 STAKEHOLDERS 30
2.5 RESEARCH METHODOLOGY 31
2.5.1 MARKET SIZE ESTIMATION 33
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 35
2.5.3 SECONDARY SOURCES 36
2.5.4 PRIMARY SOURCES 37
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 37
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 38
2.5.7 ASSUMPTIONS 39
3 MARKET ANALYSIS 40
3.1 INTRODUCTION 40
3.2 MARKET SEGMENTATION 41
3.3 FACTORS INFLUENCING MARKET 43
3.3.1 DRIVERS AND OPPORTUNITIES 44
3.3.1.1 Increasing usage of biochips in cancer diagnostics 44
3.3.1.2 Biochips preference in personalized medicine 44
3.3.1.3 Widening application market 45
3.3.1.4 Outsourcing of biochips technology 45
3.3.1.5 Emerging Asia Pacific market 45
3.3.2 RESTRAINTS AND THREATS 46
3.3.2.1 High cost of biochips 46
3.3.2.2 Lack of standardization 47
3.3.2.3 Limited skilled personnel to work on biochips 48
3.4 REGULATORY AFFAIRS 48
3.4.1 U.S. 48
3.4.2 EUROPE 49
3.4.3 CHINA 50
3.4.4 INDIA 50
3.4.5 JAPAN 50
3.5 PORTER'S FIVE FORCE ANALYSIS 51
3.5.1 THREAT OF NEW ENTRANTS 52
3.5.2 THREAT OF SUBSTITUTES 53
3.5.3 RIVALRY AMONG EXISTING COMPETITORS 53
3.5.4 BARGAINING POWER OF SUPPLIERS 54
3.5.5 BARGAINING POWER OF BUYERS 54
3.6 PATENT ANALYSIS 54
3.7 BUYERS CRITERIA 60
3.8 TECHNOLOGY VALUE CHAIN 61
3.9 LATEST AND UPCOMING PRODUCTS 62
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 66
4 BIOCHIPS ARCHITECTURE 70
4.1 INTRODUCTION 70
4.2 COMPONENTS 70
4.3 SIZE and MATERIALS USED 74
4.4 COST 74
5 BIOCHIPS GLOBAL MARKET, BY TYPES 75
5.1 INTRODUCTION 75
5.2 MICROARRAYS 78
5.2.1 DNA MICROARRAYS 80
5.2.1.1 Spotted microarrays 82
5.2.1.2 Oligonucleotide microarrays 83
5.2.1.3 Other DNA microarrays 83
5.2.2 PROTEIN MICROARRAYS 84
5.2.2.1 Analytical protein microarrays 86
5.2.2.2 Functional protein microarrays 86
5.2.2.3 Reverse phase protein microarrays 87
5.2.2.4 Cell free expressed protein microarrays 88
5.2.3 TISSUE MICROARRAYS 89
5.2.4 OTHER MICROARRAYS 90
5.3 LAB-ON-A-CHIP 92
5.3.1 PCR-ON-A-CHIP 95
5.3.2 IMMUNOASSAYS-ON-A-CHIP 97
5.3.3 ELECTROPHORESIS-ON-A-CHIP 99
5.3.4 FLOW CYTOMETRY ON A CHIP 101
5.3.5 MASS SPECTROMETRY ON A CHIP 103
5.3.6 MICROFLUIDIC CELL CUTURE 105
5.3.7 NGS-ON-A-CHIP 107
5.3.8 ORGAN-ON-A-CHIP and HUMAN-ON-A-CHIP 109
6 BIOCHIPS GLOBAL MARKET, BY PRODUCTS 112
6.1 INTRODUCTION 112
6.2 INSTRUMENTS 114
6.3 REAGENTS AND CONSUMABLES 117
6.4 SOFTWARE 119
6.5 SERVICES 121
7 BIOCHIPS GLOBAL MARKET, BY APPLICATIONS 124
7.1 INTRODUCTION 124
7.2 DIAGNOSTICS 126
7.2.1 IN-VITRO DIAGNOSTICS 128
7.2.2 CANCER DIAGNOSTICS 130
7.2.3 POINT-OF-CARE DIAGNOSTICS 132
7.3 DRUG DISCOVERY and DEVELOPMENT 135
7.3.1 HIGH THROUGHPUT SCREENING (HTS) 137
7.3.2 DRUG DELIVERY SYSTEMS 140
7.3.3 PHARMACOGENOMICS 142
7.4 RESEARCH 143
7.4.1 GENOMICS 145
7.4.2 PROTEOMICS 147
7.5 FORENSICS 149
7.6 OTHERS 151
8 BIOCHIPS GLOBAL MARKET, BY END-USERS 154
8.1 INTRODUCTION 154
8.2 PHARMACEUTICAL AND BIOTECH COMPANIES 156
8.3 ACADEMIC and RESEARCH LABORATORIES 158
8.4 DIAGNOSTIC LABORATORIES 159
8.5 CONTRACT RESEARCH ORGANISATIONS 161
8.6 OTHERS 162
9 REGIONAL MARKET ANALYSIS 164
9.1 INTRODUCTION 164
9.2 NORTH AMERICA 166
9.2.1 U.S. 166
9.3 EUROPE 177
9.4 ASIA PACIFIC 189
9.5 REST OF THE WORLD 199
10 COMPANY DEVELOPMENTS 211
10.1 INTRODUCTION 211
10.1.1 NEW PRODUCT LAUNCHES AS A MAJOR GROWTH STRATEGY OF BIOCHIPS
MARKET PLAYERS 211
10.2 NEW PRODUCT LAUNCH 213
10.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES 223
10.4 APPROVALS 231
10.5 MERGERS AND ACQUISITIONS 234
10.6 OTHER DEVELOPMENTS 238
11 MAJOR PLAYER PROFILES 241
11.1 AFFYMETRIX, INC. 241
11.1.1 OVERVIEW 241
11.1.2 FINANCIALS 242
11.1.3 PRODUCT PORTFOLIO 245
11.1.4 KEY DEVELOPMENTS 247
11.1.5 BUSINESS STRATEGY 250
11.1.6 SWOT ANALYSIS 251
11.2 AGILENT TECHNOLOGIES, INC. 252
11.2.1 OVERVIEW 252
11.2.2 FINANCIALS 253
11.2.3 PRODUCT PORTFOLIO 255
11.2.4 KEY DEVELOPMENTS 258
11.2.5 BUSINESS STRATEGY 260
11.2.6 SWOT ANALYSIS 261
11.3 BIO-RAD LABORATORIES 262
11.3.1 OVERVIEW 262
11.3.2 FINANCIALS 263
11.3.3 PRODUCT PORTFOLIO 265
11.3.4 KEY DEVELOPMENTS 267
11.3.5 BUSINESS STRATEGY 268
11.3.6 SWOT ANALYSIS 269
11.4 CEPHEID, INC. 270
11.4.1 OVERVIEW 270
11.4.2 FINANCIALS 271
11.4.3 PRODUCT PORTFOLIO 273
11.4.4 KEY DEVELOPMENTS 276
11.4.5 BUSINESS STRATEGY 280
11.4.6 SWOT ANALYSIS 281
11.5 FLUIDIGM CORPORATION. 282
11.5.1 OVERVIEW 282
11.5.2 FINANCIALS 283
11.5.3 PRODUCT PORTFOLIO 285
11.5.4 KEY DEVELOPMENTS 290
11.5.5 BUSINESS STRATEGY 291
11.5.6 SWOT ANALYSIS 292
11.6 GE HEALTHCARE 293
11.6.1 OVERVIEW 293
11.6.2 FINANCIALS 294
11.6.3 PRODUCT PORTFOLIO 296
11.6.4 KEY DEVELOPMENTS 297
11.6.5 BUSINESS STRATEGY 299
11.6.6 SWOT ANALYSIS 300
11.7 HOFFMANN-LA ROCHE LTD. 301
11.7.1 OVERVIEW 301
11.7.2 FINANCIALS 302
11.7.3 PRODUCT PORTFOLIO 304
11.7.4 KEY DEVELOPMENTS 307
11.7.5 BUSINESS STRATEGY 309
11.7.6 SWOT ANALYSIS 310
11.8 ILLUMINA, INC. 311
11.8.1 OVERVIEW 311
11.8.2 FINANCIALS 312
11.8.3 PRODUCT PORTFOLIO 313
11.8.4 KEY DEVELOPMENTS 318
11.8.5 BUSINESS STRATEGY 321
11.8.6 SWOT ANALYSIS 322
11.9 PERKINELMER, INC. 323
11.9.1 OVERVIEW 323
11.9.2 FINANCIALS 324
11.9.3 PRODUCT PORTFOLIO 327
11.9.4 KEY DEVELOPMENTS 328
11.9.5 BUSINESS STRATEGY 330
11.9.6 SWOT ANALYSIS 332
11.10 THERMO FISHER SCIENTIFIC, INC. 333
11.10.1 OVERVIEW 333
11.10.2 FINANCIALS 334
11.10.3 PRODUCT PORTFOLIO 337
11.10.4 KEY DEVELOPMENTS 339
11.10.5 BUSINESS STRATEGY 341
11.10.6 SWOT ANALYSIS 342

LIST OF TABLES

TABLE 1 BIOCHIPS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 21
TABLE 2 BIOCHIPS GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 22
TABLE 3 BIOCHIPS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 23
TABLE 4 BIOCHIPS GLOBAL MARKET REVENUE, BY APPLICATION TYPE (2013-2021) ($MN) 24
TABLE 5 BIOCHIPS GLOBAL MARKET REVENUE, BY END USERS TYPE, (2013-2021) ($MN) 25
TABLE 6 RECENT BIOCHIPS RELATED PATENTS (2015) 56
TABLE 7 RECENT AND UPCOMING PRODUCTS 62
TABLE 8 BIOCHIPS GLOBAL MARKET REVENUE, BY TYPE (2013-2021) ($MN) 78
TABLE 9 MICROARRAYS GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 79
TABLE 10 MICROARRAYS GLOBAL MARKET REVENUE, BY TYPE (2013-2021) ($MN) 80
TABLE 11 DNA MICROARRAYS GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 81
TABLE 12 PROTEIN MICROARRAYS GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 85
TABLE 13 TISSUE MICROARRAYS GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 90
TABLE 14 OTHER MICROARRAYS GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 92
TABLE 15 LAB-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 94
TABLE 16 LAB-ON-A-CHIP GLOBAL MARKET REVENUE, BY TYPE (2013-2021) ($MN) 95
TABLE 17 PCR-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 97
TABLE 18 IMMUNOASSAY-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION
(2013-2021) ($MN) 99
TABLE 19 ELECTROPHORESIS-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION
(2013-2021) ($MN) 101
TABLE 20 FLOW CYTOMETRY-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION
(2013-2021) ($MN) 103
TABLE 21 MASS SPECTROMETRY-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION
(2013-2021) ($MN) 105
TABLE 22 MICROFLUIDIC CELL CULTURE GLOBAL MARKET REVENUE, BY REGION
(2013-2021) ($MN) 107
TABLE 23 NGS-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION (2013-2021) ($MN) 109
TABLE 24 ORGAN-ON-A-CHIP GLOBAL MARKET REVENUEY, BY REGION (2013-2021) ($MN) 111
TABLE 25 BIO-CHIPS GLOBAL MARKET REVENUE, BY PRODUCTS, (2013-2021) ($MN) 114
TABLE 26 INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 116
TABLE 27 REAGENT AND CONSUMABLES GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 118
TABLE 28 SOFTWARE MARKET REVENUE, BY REGION, (2013-2021) ($MN) 121
TABLE 29 SERVICES MARKET REVENUE, BY REGION, (2013-2021) ($MN) 123
TABLE 30 BIO-CHIPS GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 126
TABLE 31 DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 127
TABLE 32 DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 128
TABLE 33 IN-VITRO DIAGNOSIS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 130
TABLE 34 CANCER DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 132
TABLE 35 POINT OF CARE DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 134
TABLE 36 DRUG DISCOVERY AND DEVELOPMENT GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 136
TABLE 37 DRUG DISCOVERY AND DEVELOPMENT GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 137
TABLE 38 HIGH THROUGHPUT SCREENING GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 139
TABLE 39 DRUG DELIVERY SYSTEMS GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 141
TABLE 40 PHARMACOGENOMICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 143
TABLE 41 RESEARCH GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 144
TABLE 42 RESEARCH GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 145
TABLE 43 GENOMICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 147
TABLE 44 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 149
TABLE 45 FORENSICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 151
TABLE 46 OTHERS (APPLICATION) GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 153
TABLE 47 BIOCHIPS GLOBAL END USERS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 156
TABLE 48 PHARMACEUTICALS AND BIOTECH COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 157
TABLE 49 ACADEMICS and RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 159
TABLE 50 DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 160
TABLE 51 CRO'S GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 162
TABLE 52 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 163
TABLE 53 NORTH AMERICAN BIOCHIPS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 169
TABLE 54 NORTH AMERICAN MICROARRAYS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 170
TABLE 55 NORTH AMERICAN LAB-ON-CHIPS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 171
TABLE 56 NORTH AMERICAN BIOCHIPS PRODUCTS MARKET REVENUE, BY TYPE
(2013-2021) ($MN) 172
TABLE 57 NORTH AMERICAN BIOCHIPS APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 173
TABLE 58 NORTH AMERICAN DIAGNOSTIC APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 174
TABLE 59 NORTH AMERICAN DRUG DISCOVERY AND DEVELOPMENT APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 175
TABLE 60 NORTH AMERICAN RESEARCH APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 176
TABLE 61 NORTH AMERICAN END USERS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 177
TABLE 62 EUROPEAN BIOCHIPS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 180
TABLE 63 EUROPEAN MICROARRAYS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 181
TABLE 64 EUROPEAN LAB-ON-CHIPS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 182
TABLE 65 EUROPEAN BIOCHIPS PRODUCTS MARKET REVENUE, BY TYPE (2013-2021) ($MN) 183
TABLE 66 EUROPEAN BIOCHIPS APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 184
TABLE 67 EUROPEAN DIAGNOSTIC APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 185
TABLE 68 EUROPEAN DRUG DISCOVERY AND DEVELOPMENT APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 186
TABLE 69 EUROPEAN RESEARCH APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 187
TABLE 70 EUROPEAN END USERS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 188
TABLE 71 ASIA PACIFIC BIOCHIPS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 191
TABLE 72 ASIA PACIFIC MICROARRAYS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 192
TABLE 73 ASIA PACIFIC LAB-ON-CHIPS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 193
TABLE 74 ASIA PACIFIC BIOCHIPS PRODUCTS MARKET REVENUE, BY TYPE (2013-2021) ($MN) 194
TABLE 75 ASIA PACIFIC BIOCHIPS APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 195
TABLE 76 ASIA PACIFIC DIAGNOSTIC APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 196
TABLE 77 ASIA PACIFIC DRUG DISCOVERY AND DEVELOPMENT APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 197
TABLE 78 ASIA PACIFIC RESEARCH APPLICATION MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 198
TABLE 79 ASIA PACIFIC END USERS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 199
TABLE 80 ROW BIOCHIPS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 202
TABLE 81 ROW MICROARRAYS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 203
TABLE 82 ROW LAB-ON-CHIPS MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 204
TABLE 83 ROW BIOCHIPS PRODUCTS MARKET REVENUE, BY TYPE (2013-2021) ($MN) 205
TABLE 84 ROW BIOCHIPS APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 206
TABLE 85 ROW DIAGNOSTIC APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 207
TABLE 86 ROW DRUG DISCOVERY AND DEVELOPMENT APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 208
TABLE 87 ROW RESEARCH APPLICATION MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 209
TABLE 88 ROW END USERS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 210
TABLE 89 NEW PRODUCT LAUNCHES, (2012-2015) 213
TABLE 90 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURE, (2012-2015) 224
TABLE 91 APPROVALS, (2012-2015) 232
TABLE 92 MERGERS AND ACQUISITIONS, (2012-2015) 235
TABLE 93 OTHER DEVELOPMENTS (2012-2015) 239
TABLE 94 AFFYMETRIX, INC.: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 242
TABLE 95 AFFYMETRIX, INC.: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 243
TABLE 96 AFFYMETRIX, INC.: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 244
TABLE 97 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE AND RandD EXPENSES
(2012-2014) ($MN) 253
TABLE 98 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($MN) 254
TABLE 99 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 255
TABLE 100 BIO-RAD LABORATORIES: TOTAL REVENUE AND RandD EXPENSES
(2012-2014) ($MN) 263
TABLE 101 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 263
TABLE 102 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 264
TABLE 103 CEPHEID, INC.: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 271
TABLE 104 CEPHEID, INC.: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 272
TABLE 105 CEPHEID, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 273
TABLE 106 FLUIDIGM CORPORATION: OPERATIONAL REVENUE AND RandD EXPENSES
(2012-2014) ($MN) 283
TABLE 107 FLUIDIGM CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 284
TABLE 108 FLUIDIGM CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 285
TABLE 109 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND RandD EXPENSES
(2012 - 2014) ($BN) 294
TABLE 110 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($BN) 295
TABLE 111 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($BN) 296
TABLE 112 ROCHE'S: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 302
TABLE 113 ROCHE'S: TOTAL REVENUE, BY SEGMENTS, 302
(2012-2014) ($MN) 302
TABLE 114 ROCHE'S: DIAGNOSTICS REVENUE, BY SEGMENTS, 303
(2012-2014) ($MN) 303
TABLE 115 ROCHE'S: DIAGNOSTIC REVENUE, BY GEOGRAPHY 304
(2012-2014) ($MN) 304
TABLE 116 ILLUMINA INC: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 312
TABLE 117 ILLUMINA INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 313
TABLE 118 PERKINELMER, INC.: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 324
TABLE 119 PERKINELMER, INC.: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 325
TABLE 120 PERKINELMER, INC.: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 326
TABLE 121 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE AND RandD EXPENSES
(2012-2014) ($BN) 334
TABLE 122 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS
(2012-2014) ($BN) 335
TABLE 123 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY
(2012-2014) ($BN) 336












LIST OF FIGURES

FIGURE 1 GLOBAL BIOCHIPS MARKET SHARE AND REVENUE, BY REGION (2013-2021) 20
FIGURE 2 RESEARCH METHODOLOGY: BIOCHIPS GLOBAL MARKET 32
FIGURE 3 BIOCHIPS MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 33
FIGURE 4 BIOCHIPS MARKET: FORECASTING MODEL 34
FIGURE 5 BIOCHIPS MARKET: MARKET BREAKDOWN and DATA TRIANGULATION 35
FIGURE 6 BIOCHIPS MARKET SEGMENTATION 42
FIGURE 7 MARKET DYNAMICS 43
FIGURE 8 BIOCHIPS MARKET: PORTER'S ANALYSIS 52
FIGURE 9 BIOCHIPS MARKET: BUYERS CRITERIA 60
FIGURE 10 BIOCHIPS MARKET: TECHNOLOGY VALUE CHAIN 61
FIGURE 11 BIOCHIPS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 66
FIGURE 12 GLOBAL BIOCHIPS MARKET REVENUE, BY TYPE, (2014 V'S 2021), ($MN) 77
FIGURE 13 BIOCHIPS GLOBAL MARKET REVENUE,BY PRODUCTS, (2014 V'S 2021) ($MN) 113
FIGURE 14 BIOCHIPS GLOBAL MARKET REVENUE, BY APPLICATIONS, (2014 V'S 2021) ($MN) 125
FIGURE 15 GLOBAL BIOCHIPS MARKET REVENUE, BY END USERS (2014 V'S 2021) ($MN) 155
FIGURE 16 GLOBAL BIOCHIPS MARKET REVENUE, BY REGION (2013-2021) ($MN) 165
FIGURE 17 NORTH AMERICAN BIOCHIPS MARKET SIZE, BY TYPE, PRODUCT, APPLICATION and
END-USER OUTLOOK, (2014 V'S 2021) 168
FIGURE 18 EUROPEAN BIOCHIPS MARKET SIZE, BY TYPE, PRODUCT, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 179
FIGURE 19 ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, PRODUCT, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 190
FIGURE 20 ROW BIOCHIPS MARKET SIZE, BY TYPE, PRODUCT, APPLICATION and
END-USER OUTLOOK, (2014 V'S 2021) 201
FIGURE 21 KEY GROWTH STRATEGIES, (2012-2014) 212
FIGURE 22 SWOT: AFFYMETRIX, INC. 251
FIGURE 23 SWOT: AGILENT TECHNOLOGIES. INC, 261
FIGURE 24 SWOT: BIO-RAD LABORATORIES 269
FIGURE 25 SWOT: CEPHEID, INC. 281
FIGURE 26 SWOT ANALYSIS: FLUIDIGM CORPORATION 292
FIGURE 27 SWOT: GE HEALTHCARE 300
FIGURE 28 SWOT: HOFFMAN-LA-ROCHE LTD 310
FIGURE 29 SWOT: ILLUMINA, INC. 322
FIGURE 30 SWOT: PERKINELMER, INC. 332
FIGURE 31 SWOT: THERMO FISHER SCIENTIFIC 342

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Proteomics Market: By Technology (Chromatography, Mass Spectroscopy, Others), By Product Type (Instruments, Reagents, Others), By Services (Laboratory, Data Analysis), By End-User (Drug discovery, Clinical Diagnosis, and Others) & By Region-Forecast (2016

Proteomics Market: By Technology (Chromatography, Mass Spectroscopy, Others), By Product Type (Instruments, Reagents, Others), By Services (Laboratory, Data Analysis), By End-User (Drug discovery, Clinical Diagnosis, and Others) & By Region-Forecast (2016

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Proteomic is a systematic study of proteome on a broader way to collect information on protein abundances, their variations and modifications, along with their interacting partners and networks, in orde ...

Proteomics Market Analysis by Product, by Technology, by Application, and Segment Forecasts to 2024

Proteomics Market Analysis by Product, by Technology, by Application, and Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The global proteomics market is expected to reach over USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc. The introduction of technology-enabled proteomics products is one ...

Biochip Market Analysis by Type, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use, and Segment Forecasts to 2024

Biochip Market Analysis by Type, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use, and Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements ...


Download Unlimited Documents from Trusted Public Sources

Genome Sequencing Industry in Australia

  • November 2016
    126 pages
  • Genome Sequenci...  

  • Australia  

    United States  

View report >

Genome Sequencing Industry in Australia

  • November 2016
    126 pages
  • Genome Sequenci...  

  • Australia  

    United States  

View report >

Bioinformatic Supply in the US - Forecast

  • November 2016
  • Bioinformatic  

    DNA  

    Chemical  

  • United States  

View report >

Rna Industry In The Us

2 months ago

Rna Industry In The Us

3 months ago

Dna Industry In The Us

3 months ago

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.